Search Results 471-480 of 17155 for Alkaptonuria
About this study. This is a Phase Ib, open-label, randomized, multicenter, two-arm study designed to assess the safety, efficacy, and pharmacokinetics of ...
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with ...
About this study. The aim of the clinical trial is evaluate the EndoRotor®'s ability to completely remove areas of Barrett's metaplasia considered ...
The purpose of this study is to assess the safety and effectiveness of AXS-12 in narcoleptic subjects with cataplexy and excessive daytime sleepiness (EDS).
About this study. The purpose of this study is to use samples from multiple patients to validate and provide detailed mapping of food to identify allergen ...
About this study. The purposes of this study are to measure the impact of two doses of ALZT-OP1a (cromolyn) on neuro-inflammation by measuring plasma ...
About this study. The purpose of this study is to characterize and compare sensorimotor activity in muscles below the level of injury during Transcutaneous ...
Mr. Ma was misdiagnosed at home and experienced a few unsuccessful treatments. His daughter brought Mr. Ma to Mayo Clinic where the patient's rare and ...
Iptacopan is used to treat a type of blood disease called paroxysmal nocturnal hemoglobinuria (PNH). This medicine helps reduce red blood cell destruction or ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.